nach oben

Erschienen in:

01.06.2019 | Clinical study

Serious adverse GI events with sodium polystyrene sulfonate

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Treatment of hyperkalaemic older patients with sodium polystyrene sulfonate is associated with an increased risk of serious gastrointestinal (GI) events, according to study results reported in JAMA Internal Medicine, which suggests "caution with the ongoing use". …

Noel JA, et al. Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age. JAMA Internal Medicine : 10 Jun 2019. Available from: URL: http://doi.org/10.1001/jamainternmed.2019.0631

Parks M, et al. Sodium Polystyrene Sulfonate for Hyperkalemia. JAMA Internal Medicine : 10 Jun 2019. Available from: URL: http://doi.org/10.1001/jamainternmed.2019.1291

Titel: Serious adverse GI events with sodium polystyrene sulfonate
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63902-2

Springer Medizin

Serious adverse GI events with sodium polystyrene sulfonate

Excerpt

Weitere Artikel der Ausgabe 1/2019

Nitrous oxide toxicity

Decitabine

Infliximab

Methotrexate/prednisolone/tocilizumab

Sirolimus

Emtricitabine/tenofovir

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Nitrous oxide toxicity

Decitabine

Infliximab

Methotrexate/prednisolone/tocilizumab

Sirolimus

Emtricitabine/tenofovir